Recent investigations into semaglutide are highlighting remarkable capabilities beyond current purpose for type 2 diabetes. Researchers are closely investigating how this GLP-1 receptor agonist impacts weight management, the heart, and even brain health. These findings point to a broad array of therapeutic opportunities, driving additional study an